Sam Hutcheson, Aimee Pehrson, Robert B Gassert, Ethan Guffey, Paul C Shanahan, Laura Sisk, Samuel Patton, Che Antonio Solla
{"title":"术后阿片类药物诱导呼吸抑制的风险分层:回顾性病例-对照分析现有有效工具。","authors":"Sam Hutcheson, Aimee Pehrson, Robert B Gassert, Ethan Guffey, Paul C Shanahan, Laura Sisk, Samuel Patton, Che Antonio Solla","doi":"10.2147/JPR.S495181","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Postoperative opioid-induced respiratory depression (POIRD) is a preventable perioperative cause of morbidity and mortality. A validated POIRD risk stratification tool could reduce these complications. 3 pre-existing validated opioid tools; and specific risk factors identified from these tools; were examined in this retrospective case-control study to determine if they could assess POIRD risk in patients discharged to hospital floors from the Post-Anesthesia Care Unit (PACU).</p><p><strong>Patients and methods: </strong>Our dataset includes 126 matched patients who underwent surgery at the University of Tennessee Medical Center from January 2019 to December 2021. All patients that were related to active traumas or burns were excluded from this study. Escalation of care secondary to respiratory failure (an increase in respiratory support with movement to an intensive care unit/stepdown unit or patient expiration secondary to respiratory failure) with and without naloxone administration was the primary endpoint; with the subgroup that received naloxone being the surrogate POIRD endpoint. Escalation of care secondary to respiratory failure; regardless of naloxone use; was a secondary endpoint.</p><p><strong>Results: </strong>There was no association between the 3 opioid tools evaluated with the POIRD surrogate endpoint or escalation of care. Bipolar disorder (OR 3.68; 95% CI 1.11-9.56) and a history of substance abuse (OR 26.33; 95% CI 5.18-119.02) were significant risk factors that contributed to escalation of care secondary to respiratory failure. A history of substance abuse was found to have a significant association with escalation of care secondary to respiratory failure with naloxone administration (OR=6.886; 95% CI 2.02-23.56).</p><p><strong>Conclusion: </strong>While we were unable to identify a tool to stratify POIRD risk; patients with bipolar disorder and a history of substance abuse are at an increased risk of postoperative respiratory failure requiring escalation of care; with a history of substance abuse being associated with POIRD.</p>","PeriodicalId":16661,"journal":{"name":"Journal of Pain Research","volume":"18 ","pages":"2233-2240"},"PeriodicalIF":2.5000,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12047283/pdf/","citationCount":"0","resultStr":"{\"title\":\"Risk Stratification for Postoperative Opioid Induced Respiratory Depression: A Retrospective Case-Control Analysis of Existing Validated Tools.\",\"authors\":\"Sam Hutcheson, Aimee Pehrson, Robert B Gassert, Ethan Guffey, Paul C Shanahan, Laura Sisk, Samuel Patton, Che Antonio Solla\",\"doi\":\"10.2147/JPR.S495181\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>Postoperative opioid-induced respiratory depression (POIRD) is a preventable perioperative cause of morbidity and mortality. A validated POIRD risk stratification tool could reduce these complications. 3 pre-existing validated opioid tools; and specific risk factors identified from these tools; were examined in this retrospective case-control study to determine if they could assess POIRD risk in patients discharged to hospital floors from the Post-Anesthesia Care Unit (PACU).</p><p><strong>Patients and methods: </strong>Our dataset includes 126 matched patients who underwent surgery at the University of Tennessee Medical Center from January 2019 to December 2021. All patients that were related to active traumas or burns were excluded from this study. Escalation of care secondary to respiratory failure (an increase in respiratory support with movement to an intensive care unit/stepdown unit or patient expiration secondary to respiratory failure) with and without naloxone administration was the primary endpoint; with the subgroup that received naloxone being the surrogate POIRD endpoint. Escalation of care secondary to respiratory failure; regardless of naloxone use; was a secondary endpoint.</p><p><strong>Results: </strong>There was no association between the 3 opioid tools evaluated with the POIRD surrogate endpoint or escalation of care. Bipolar disorder (OR 3.68; 95% CI 1.11-9.56) and a history of substance abuse (OR 26.33; 95% CI 5.18-119.02) were significant risk factors that contributed to escalation of care secondary to respiratory failure. A history of substance abuse was found to have a significant association with escalation of care secondary to respiratory failure with naloxone administration (OR=6.886; 95% CI 2.02-23.56).</p><p><strong>Conclusion: </strong>While we were unable to identify a tool to stratify POIRD risk; patients with bipolar disorder and a history of substance abuse are at an increased risk of postoperative respiratory failure requiring escalation of care; with a history of substance abuse being associated with POIRD.</p>\",\"PeriodicalId\":16661,\"journal\":{\"name\":\"Journal of Pain Research\",\"volume\":\"18 \",\"pages\":\"2233-2240\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2025-04-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12047283/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pain Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2147/JPR.S495181\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pain Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/JPR.S495181","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的:术后阿片类药物引起的呼吸抑制(POIRD)是围手术期可预防的发病和死亡原因。经过验证的POIRD风险分层工具可以减少这些并发症。3个预先存在的经过验证的阿片类药物工具;以及从这些工具中确定的具体风险因素;在这项回顾性病例对照研究中进行了检查,以确定它们是否可以评估从麻醉后护理病房(PACU)出院到医院楼层的患者的POIRD风险。患者和方法:我们的数据集包括2019年1月至2021年12月在田纳西大学医学中心接受手术的126名匹配患者。所有与活动创伤或烧伤相关的患者均被排除在本研究之外。使用纳洛酮和不使用纳洛酮的主要终点是继发于呼吸衰竭的护理升级(随着进入重症监护病房/降压病房或继发于呼吸衰竭的患者死亡而增加的呼吸支持);接受纳洛酮治疗的亚组作为替代POIRD终点。继发于呼吸衰竭的护理升级;不管纳洛酮的使用;是次要终点。结果:与POIRD替代终点或护理升级评估的3种阿片类药物工具之间没有关联。双相情感障碍(OR 3.68;95% CI 1.11-9.56)和药物滥用史(OR 26.33;95% CI 5.18-119.02)是导致呼吸衰竭继发护理升级的重要危险因素。药物滥用史与纳洛酮给药后继发于呼吸衰竭的护理升级有显著关联(OR=6.886;95% ci 2.02-23.56)。结论:虽然我们无法确定一种工具来对POIRD风险进行分层;双相情感障碍患者和有药物滥用史的患者术后呼吸衰竭的风险增加,需要升级护理;有与POIRD相关的药物滥用史。
Risk Stratification for Postoperative Opioid Induced Respiratory Depression: A Retrospective Case-Control Analysis of Existing Validated Tools.
Purpose: Postoperative opioid-induced respiratory depression (POIRD) is a preventable perioperative cause of morbidity and mortality. A validated POIRD risk stratification tool could reduce these complications. 3 pre-existing validated opioid tools; and specific risk factors identified from these tools; were examined in this retrospective case-control study to determine if they could assess POIRD risk in patients discharged to hospital floors from the Post-Anesthesia Care Unit (PACU).
Patients and methods: Our dataset includes 126 matched patients who underwent surgery at the University of Tennessee Medical Center from January 2019 to December 2021. All patients that were related to active traumas or burns were excluded from this study. Escalation of care secondary to respiratory failure (an increase in respiratory support with movement to an intensive care unit/stepdown unit or patient expiration secondary to respiratory failure) with and without naloxone administration was the primary endpoint; with the subgroup that received naloxone being the surrogate POIRD endpoint. Escalation of care secondary to respiratory failure; regardless of naloxone use; was a secondary endpoint.
Results: There was no association between the 3 opioid tools evaluated with the POIRD surrogate endpoint or escalation of care. Bipolar disorder (OR 3.68; 95% CI 1.11-9.56) and a history of substance abuse (OR 26.33; 95% CI 5.18-119.02) were significant risk factors that contributed to escalation of care secondary to respiratory failure. A history of substance abuse was found to have a significant association with escalation of care secondary to respiratory failure with naloxone administration (OR=6.886; 95% CI 2.02-23.56).
Conclusion: While we were unable to identify a tool to stratify POIRD risk; patients with bipolar disorder and a history of substance abuse are at an increased risk of postoperative respiratory failure requiring escalation of care; with a history of substance abuse being associated with POIRD.
期刊介绍:
Journal of Pain Research is an international, peer-reviewed, open access journal that welcomes laboratory and clinical findings in the fields of pain research and the prevention and management of pain. Original research, reviews, symposium reports, hypothesis formation and commentaries are all considered for publication. Additionally, the journal now welcomes the submission of pain-policy-related editorials and commentaries, particularly in regard to ethical, regulatory, forensic, and other legal issues in pain medicine, and to the education of pain practitioners and researchers.